Biochanin A as an α-hemolysin inhibitor for combating methicillin-resistant Staphylococcus aureus infection
In conclusion, biochanin A protected the host from MRSA infection by inhibiting the expression of the hemolysin of MRSA, which may provide experimental evidence for its development to a potential anti-MRSA drug.
Source: World Journal of Microbiology and Biotechnology - Category: Microbiology Source Type: research
More News: Alfalfa | Biotechnology | Cabbage | Infectious Diseases | Microbiology | MRSA | Multidrug Resistance | Pneumonia | Red Clover | Staphylococcus Aureus | Study | Superbugs